NR4A2 and malignant colon neoplasm: In colon cancer, it has been demonstrated that prostaglandin E2 mediated proliferation is inhibited by expression of a dominant negative NURR1, demonstrating that NURR1 is indeed necessary for eicosanoid-mediated proliferation in colon cancer[21].